Free Trial

Altimmune (ALT) Short Interest Ratio & Short Volume

$7.33
-0.06 (-0.81%)
(As of 05/24/2024 ET)

Altimmune Short Interest Data

Current Short Interest
22,310,000 shares
Previous Short Interest
20,370,000 shares
Change Vs. Previous Month
+9.52%
Dollar Volume Sold Short
$146.13 million
Short Interest Ratio
4.9 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
70,900,000 shares
Percentage of Shares Shorted
31.47%
Today's Trading Volume
1,715,778 shares
Average Trading Volume
3,054,106 shares
Today's Volume Vs. Average
56%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Altimmune ?

Sign up to receive the latest short interest report for Altimmune and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ALT Short Interest Over Time

ALT Days to Cover Over Time

ALT Percentage of Float Shorted Over Time

Altimmune Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202422,310,000 shares $146.13 million +9.5%N/A4.9 $6.55
4/15/202420,370,000 shares $153.79 million +14.9%N/A4.3 $7.55
3/31/202417,730,000 shares $180.49 million +41.7%N/A3.2 $10.18
3/15/202412,510,000 shares $123.35 million +15.7%N/A1.9 $9.86
2/29/202410,810,000 shares $130.80 million -6.4%N/A1.1 $12.10
2/15/202411,550,000 shares $103.37 million +15.4%N/A1 $8.95
1/31/202410,010,000 shares $94.49 million -6.1%N/A0.9 $9.44
1/15/202410,660,000 shares $127.92 million +12.9%N/A1 $12.00
12/31/20239,440,000 shares $106.20 million -14.9%N/A1 $11.25
12/15/202311,090,000 shares $85.06 million +71.9%N/A1.3 $7.67
11/30/20236,450,000 shares $20.38 million -4.2%N/A1 $3.16
11/15/20236,730,000 shares $16.42 million -1.9%N/A5.8 $2.44
10/31/20236,860,000 shares $16.53 million -7.3%N/A5.9 $2.41
10/15/20237,400,000 shares $19.68 million +3.5%N/A6.9 $2.66
9/30/20237,150,000 shares $18.59 million +9.3%N/A6.5 $2.60
9/15/20236,540,000 shares $19.10 million +8.5%N/A5.3 $2.92
8/31/20236,030,000 shares $15.26 million +4.3%N/A3.7 $2.53
8/15/20235,780,000 shares $16.24 million -6.2%N/A3.3 $2.81
7/31/20236,160,000 shares $20.39 million -16.2%N/A3.4 $3.31
7/15/20237,350,000 shares $24.11 million +5.6%N/A4.1 $3.28
6/30/20236,960,000 shares $24.57 million -23.8%N/A3.6 $3.53
6/15/20239,130,000 shares $37.34 million +0.6%N/A4.3 $4.09
5/31/20239,080,000 shares $36.68 million +2.6%N/A4.2 $4.04
5/15/20238,850,000 shares $42.92 million -2.1%N/A4.3 $4.85
4/30/20239,040,000 shares $45.65 million -8.3%N/A4.5 $5.05
4/15/20239,860,000 shares $47.13 million +3.8%N/A4.8 $4.78
3/31/20239,500,000 shares $40.09 million +28.4%N/A4.9 $4.22
3/15/20237,400,000 shares $80.88 million +16.0%N/A3.9 $10.93
2/28/20236,380,000 shares $80.32 million +1.9%N/A4.6 $12.59
2/15/20236,260,000 shares $75.06 million +1.5%N/A4.5 $11.99
1/31/20236,170,000 shares $84.16 million -15.7%N/A4.3 $13.64
1/15/20237,320,000 shares $119.24 million -3.4%N/A5.3 $16.29
12/30/20227,580,000 shares $124.69 million +19.6%N/A5.6 $16.45
12/15/20226,340,000 shares $66.38 million -3.4%N/A4.5 $10.47
11/30/20226,560,000 shares $65.27 million -10.0%N/A2.9 $9.95
11/15/20227,290,000 shares $79.61 million +1.8%N/A3.2 $10.92
10/31/20227,160,000 shares $89.79 million +1.6%N/A2.9 $12.54
10/15/20227,050,000 shares $73.32 million -8.4%N/A2.9 $10.40
9/30/20227,700,000 shares $98.33 million +13.9%N/A3.1 $12.77
9/15/20226,760,000 shares $97.28 million +9.7%N/A2.6 $14.39
Memorial Day Sale! Get 90% OFF Behind the Markets! (Ad)

Today, I'm offering you the chance to receive a PLATINUM BTM subscription for up to 90% OFF! If you want to see just how much your mystery discount is...

You can UNCOVER YOUR MYSTERY DISCOUNT HERE!
8/31/20226,160,000 shares $136.01 million +26.8%N/A3.3 $22.08
8/15/20224,860,000 shares $85.24 million No ChangeN/A2.9 $17.54
7/31/20224,860,000 shares $58.37 million +10.5%N/A3.2 $12.01
7/15/20224,400,000 shares $49.85 million -26.3%N/A3.1 $11.33
6/30/20225,970,000 shares $69.85 million -3.1%N/A4.5 $11.70
6/15/20226,160,000 shares $51.25 million +56.4%N/A5.4 $8.32
5/31/20223,940,000 shares $19.94 million +2.3%N/A4.7 $5.06
5/15/20223,850,000 shares $19.87 million +27.5%N/A4.5 $5.16
4/30/20223,020,000 shares $13.65 million +6.3%N/A3.6 $4.52
4/15/20222,840,000 shares $14.85 million +7.6%N/A3.3 $5.23
3/31/20222,640,000 shares $16.08 million -36.2%N/A3.2 $6.09
3/15/20224,140,000 shares $24.43 million +5.1%N/A4.8 $5.90
2/28/20223,940,000 shares $29.20 million +9.4%10.5%5.4 $7.41
2/15/20223,600,000 shares $28.58 million +6.8%9.6%5 $7.94
1/31/20223,370,000 shares $27.20 million -26.4%10.0%4.4 $8.07
1/15/20224,580,000 shares $35.91 million +2.0%13.6%6.2 $7.84
12/31/20214,490,000 shares $41.13 million +4.7%13.4%6 $9.16
12/15/20214,290,000 shares $38.95 million -0.5%12.8%4 $9.08
11/30/20214,310,000 shares $45.21 million -9.5%12.8%3.8 $10.49
11/15/20214,760,000 shares $53.12 million -15.2%14.2%3.8 $11.16
10/29/20215,610,000 shares $60.59 million -1.9%16.6%4.2 $10.80
10/15/20215,720,000 shares $68.70 million -6.7%16.9%4.3 $12.01
9/30/20216,130,000 shares $69.33 million -7.8%18.1%4.5 $11.31
9/15/20216,650,000 shares $109.92 million +4.2%19.7%4.1 $16.53
8/31/20216,380,000 shares $95.64 million +21.5%18.9%3.2 $14.99
8/13/20215,250,000 shares $63.11 million +5.0%15.5%2.7 $12.02
7/30/20215,000,000 shares $45.35 million -4.9%15.4%2.7 $9.07
7/15/20215,260,000 shares $45.34 million +13.4%16.2%2.8 $8.62
6/30/20214,640,000 shares $45.70 million +10.2%14.3%2.4 $9.85
6/15/20214,210,000 shares $59.49 million -0.5%13.0%3.2 $14.13
5/28/20214,230,000 shares $53.51 million -19.6%13.0%3.8 $12.65
5/14/20215,260,000 shares $67.01 million +4.2%N/A4.4 $12.74
4/30/20215,050,000 shares $71.81 million +4.3%N/A3.8 $14.22
4/15/20214,840,000 shares $62.68 million -10.7%N/A3.1 $12.95
3/31/20215,420,000 shares $73.44 million +82.5%N/A3.4 $13.55
3/15/20212,970,000 shares $49.78 million +23.2%N/A1.7 $16.76
2/26/20212,410,000 shares $41.45 million -4.4%N/A1.4 $17.20
2/12/20212,520,000 shares $55.64 million -3.5%N/A1.3 $22.08
1/29/20212,610,000 shares $35.10 million +0.4%N/A1.3 $13.45
1/15/20212,600,000 shares $35.28 million -11.3%N/A1.5 $13.57
12/31/20202,930,000 shares $33.11 million +17.7%N/A1.5 $11.30
12/15/20202,490,000 shares $33.22 million +14.2%N/A1.4 $13.34
11/30/20202,180,000 shares $22.93 million -9.9%N/A1.2 $10.52
11/15/20202,420,000 shares $24.51 million -16.8%N/A1.5 $10.13
10/30/20202,910,000 shares $33.26 million +25.4%N/A1.8 $11.43
10/15/20202,320,000 shares $29.70 million +11.5%N/A1.3 $12.80
9/30/20202,080,000 shares $27.46 million +41.5%N/A0.8 $13.20
9/15/20201,470,000 shares $18.30 million +44.1%N/A0.4 $12.45

ALT Short Interest - Frequently Asked Questions

What is Altimmune's current short interest?

Short interest is the volume of Altimmune shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 22,310,000 shares of ALT short. Learn More on Altimmune's current short interest.

What is a good short interest ratio for Altimmune?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALT shares currently have a short interest ratio of 5.0. Learn More on Altimmune's short interest ratio.

Which institutional investors are shorting Altimmune?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Altimmune: Walleye Trading LLC, PEAK6 Investments LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Altimmune's short interest increasing or decreasing?

Altimmune saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 22,310,000 shares, an increase of 9.5% from the previous total of 20,370,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Altimmune's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Altimmune: Y-mAbs Therapeutics, Inc. (7.47%), COMPASS Pathways plc (4.99%), SIGA Technologies, Inc. (13.53%), Olema Pharmaceuticals, Inc. (15.02%), Aerovate Therapeutics, Inc. (10.43%), Heron Therapeutics, Inc. (18.11%), Entrada Therapeutics, Inc. (9.54%), Avid Bioservices, Inc. (17.42%), Harrow, Inc. (15.55%), Astria Therapeutics, Inc. (10.24%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Altimmune stock?

Short selling ALT is an investing strategy that aims to generate trading profit from Altimmune as its price is falling. ALT shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Altimmune?

A short squeeze for Altimmune occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALT, which in turn drives the price of the stock up even further.

How often is Altimmune's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALT, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ALT) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners